Expanded testing options for PGxome and large PGxome-based tests

Published on

PreventionGenetics is excited to announce the addition of Patient Plus for PGxomeⓇ and large exome-based tests - Autism Spectrum Disorders and Intellectual Disability panel and Neonatal Crisis panel. Patient Plus involves sequencing and copy number variant (CNV) analysis of the patient, and then use of the parental specimens to perform targeted testing for the key sequence variants found in the patient. This approach permits detection of de novo variants and phasing of variants in recessive genes.

Rapid Exome-based Testing for Neonatal Crisis

Published on

PreventionGenetics’ Neonatal Crisis panel is a unique ~1,200 gene panel designed for critically ill neonatal and pediatric patients. The panel includes sequencing and copy number variation detection as well as an accelerated turnaround time. The panel has yielded ~17% clear positive results. 

Employee Spotlight: Christina Zaleski Elected Vice President of Wisconsin Genetic Counselors Association 

Published on

PreventionGenetics’ Director of Genetic Counseling and Client Services, Christina Zaleski, MS, CGC, has been elected Vice President of the Wisconsin Genetic Counselors Association (WIGCA).  This is a tremendous honor for the Wisconsin native who has dedicated her career to helping patients and helping grow her profession.

Employee Spotlight: 2018 Summer Interns

Published on

As fall approaches, our summer interns are wrapping up their projects at PreventionGenetics. The goal of our internships is to allow college students the opportunity to develop and improve their skills, while gaining real world knowledge within their field of study.  “Mentoring bright students pursuing careers in genetics is both important and rewarding for us,” said company Founder and President, James Weber, PhD. 

During the past few months, PreventionGenetics has had a record nine interns within five departments

Selecting the Right Test Just Got Easier: Connective Tissue Disorder Panels Expanded

Published on

We are pleased to announce that our Marfan Syndrome & Aortopathies Panel and our Ehlers-Danlos syndromes panels have been expanded to include a wider clinical spectrum.  

Each of our PhD experts each focuses on a specific subset of the genome. As new publications become available, we curate our gene lists and rise to the challenge to keep our test menu current.  In light of some new publications and at the request of expert clinicians, we have recently expanded a few of our connective tissue disorder panels.  Our goal is to make it easy to select the right test for your patients.